Ultra-widefield imaging extends documentation beyond the posterior pole and can reveal clinically relevant peripheral lesions. In diabetic retinopathy, prospective studies show that some fluorescein-defined peripheral patterns are associated with future worsening—but not every peripheral finding carries the same prognostic weight.
- UWF systems can capture a substantially larger retinal field in a single acquisition than conventional fundus photography.
- Peripheral lesions can change what is detected and sometimes how disease is graded, particularly in diabetic retinopathy.
- Field of view is not the same as clinical significance: geometry, artifacts and lesion type still matter.
Why the periphery was easy to under-document
Traditional fundus photography concentrates on the posterior pole, where the macula, optic nerve and major vascular arcades sit. That is efficient, but the retina extends far beyond those standard fields. Peripheral pathology historically required examination with indirect ophthalmoscopy or multiple directed photographs. Ultra-widefield systems change the documentation problem by capturing a much larger retinal area in a single image, making peripheral lesions easier to record, compare and grade.
What 'ultra-widefield' means in practice
Commercial systems can image fields approaching 200 degrees, though the exact visible retinal area depends on anatomy, lashes, lids, pupil, steering and device geometry. A wide image is also a projection of a curved surface onto a flat plane. Peripheral distortion is therefore part of the medium. Stereographic correction can help when measuring area or distance, but raw pixels should not be treated as a geometrically uniform map of the retinal surface.
The diabetic-retinopathy test case
Diabetic retinopathy has provided some of the strongest evidence for why peripheral imaging can matter. Standard ETDRS fields do not cover the entire retina. UWF imaging can reveal hemorrhages, microaneurysms and other lesions outside those fields. A prospective 2026 comparison of 769 eyes found that UWF imaging detected more DR and referable DR than two-field 45-degree photography and produced a lower ungradable rate. That demonstrates a detection advantage in that study; it does not mean every additional lesion changes treatment.
Peripheral lesions and prognosis
The more interesting question is whether peripheral findings predict what happens next. In a multicenter longitudinal DRCR Retina Network study, color-defined predominantly peripheral lesions were not independently associated with four-year worsening, while predominantly peripheral lesions identified on UWF fluorescein angiography were associated with greater risk. That distinction is important: 'peripheral lesion' is not a single biomarker, and the modality used to define it can change the prognostic signal.
A newer signal: quantified peripheral hemorrhage
The field is moving from visual labels toward quantified peripheral biomarkers. A 2026 two-year longitudinal study in an Asian cohort investigated whether peripheral hemorrhage density and predominantly peripheral lesions could predict DR progression after adjustment for ocular and systemic factors. Work like this matters because a reproducible continuous metric may ultimately be more useful than a broad yes/no label—but it still requires external validation before becoming routine risk stratification.
Beyond diabetic retinopathy
Peripheral imaging is also useful for documenting lattice degeneration, retinal tears and detachments, vascular occlusions, inflammatory lesions and inherited retinal disease patterns. The value can be practical: a baseline image helps communicate lesion extent and supports longitudinal comparison. Yet UWF photography does not recreate everything a dynamic dilated examination provides. Peripheral distortion, obscuration and limited stereopsis can matter, particularly when subtle breaks or traction are suspected.
Widefield is becoming multimodal
Field of view is expanding beyond color photography. Ultra-widefield fluorescein angiography maps peripheral leakage and nonperfusion, while newer widefield OCT and OCTA approaches attempt to extend depth-resolved structural and flow imaging. This creates a richer peripheral dataset but also a larger computational burden: montage accuracy, segmentation and projection need to remain reliable over a much greater area.
The real gain is context
The simplest description of UWF imaging is 'seeing more retina,' but the deeper value is context. A lesion near the posterior pole can be understood alongside what is happening in the periphery, and disease distributions that were previously sampled can be documented more completely. The challenge now is converting that additional visibility into validated decisions rather than assuming that more pixels automatically mean better care.
Field of view should be reported carefully
A quoted angular field is not the same as the percentage of retinal surface captured, and different manufacturers may describe fields using different conventions. Eyelid position and steering can also change what is visible in an individual acquisition. For research, standardized definitions and stereographic projection matter when comparing lesion location or area. For editorial coverage, Retina.blog will avoid treating a headline degree number as a complete description of usable peripheral coverage.
AI makes peripheral imaging a data problem
A widefield image contains more anatomy—and more opportunities for artifacts, class imbalance and spurious correlations. New AI studies are beginning to use UWF images for diabetic-retinopathy screening and lesion quantification, but external validation across devices and populations remains important. More field of view can improve information capture, yet it also increases the need for robust annotation and transparent evaluation.
Most prognostic evidence highlighted here comes from diabetic-retinopathy cohorts. The value of UWF imaging varies by disease and should not be generalized to every retinal condition.
Sources & original records
We prioritize primary records, clinical-trial registries, peer-reviewed literature and authoritative institutions. Manufacturer material is labeled when used to describe a product or company position.
- Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over TimeJAMA Ophthalmology / PubMed · 2022 · Prospective multicenter longitudinal study · PMID 35980608 · DOI 10.1001/jamaophthalmol.2022.3131
- A prospective comparison of ultrawide-field and two-field fundus imaging for diabetic retinopathy assessmentPubMed · Prospective comparative study · PMID 41792656
- Peripheral retinal haemorrhage density on ultra-widefield imaging as a novel biomarker for predicting diabetic retinopathy progressionBritish Journal of Ophthalmology / PubMed · 2026 · Prospective longitudinal study · PMID 42120190 · DOI 10.1136/bjo-2025-327940